Cite
HARVARD Citation
Kohlmann, R. et al. (2015). Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Multiple sclerosis. pp. 1823-1832. [Online].